APA (7th ed.) Citation

YL, W., HL, W., YZ, H., QY, Z., XQ, Y., CL, F., & W, T. (2026). S-Adenosylhomocysteine hydrolase inhibitor DZ2002 promotes diabetic wound healing by regulating Macrophage-Mediated inflammation through the mixed lineage leukemia 1-H3K4me3 axis. Biochemical pharmacology, 250(Pt 2), 118044. https://doi.org/10.1016/j.bcp.2026.118044

Chicago Style (17th ed.) Citation

YL, Wang, Wang HL, Hao YZ, Zhu QY, Yang XQ, Feng CL, and Tang W. "S-Adenosylhomocysteine Hydrolase Inhibitor DZ2002 Promotes Diabetic Wound Healing by Regulating Macrophage-Mediated Inflammation Through the Mixed Lineage Leukemia 1-H3K4me3 Axis." Biochemical Pharmacology 250, no. Pt 2 (2026): 118044. https://doi.org/10.1016/j.bcp.2026.118044.

MLA (9th ed.) Citation

YL, Wang, et al. "S-Adenosylhomocysteine Hydrolase Inhibitor DZ2002 Promotes Diabetic Wound Healing by Regulating Macrophage-Mediated Inflammation Through the Mixed Lineage Leukemia 1-H3K4me3 Axis." Biochemical Pharmacology, vol. 250, no. Pt 2, 2026, p. 118044, https://doi.org/10.1016/j.bcp.2026.118044.